Abstract
The visual acuity of the patient with ethambutol optic neuropathy will recover within 3 to 4 months after discontinuing the drug. We studied the extent of the recovery of other visual functions. Thirty-six axial type ethambutol optic neuropathy patients, who visited our neuro-ophthalmology clinic from January, 1990, to December, 1993, were included in this study. Fifteen patients (29 eyes) regained their visual acuity to better than 1.0. The average follow-up period following the recovery is 21.7 months. Pattern reversal VEP, Farnsworth-Munsell 100-Hue color vision test, critical flicker frequency (CFF), visual field perimetry, contrast sensitivity and edge-light pupil cycle time were assessed for every affected eye. Latency (P100) of visually evoked potential was delayed in 34.5% (10/29) of eyes. In color vision, 48.3% (14/29) of eyes had deutan or tritan defect. An abnormality of red CFF with value lower than 31 Hz was revealed 51.7% (15/29) eyes. In the visual field, 58.6% (17/29) of eyes had paracentral scotoma, arcuate scotoma, or enlargement of physiologic blind spot. Contrast sensitivity was depressed in 62.1% (18/29) of eyes, mainly at middle and low spatial frequency. Pupil cycle time was prolonged in 72.4% (21/29) of ...Continue Reading
References
Oct 11, 1975·Lancet·I A Campbell, P C Elmes
Dec 1, 1986·The British Journal of Ophthalmology·E A SandersG H van Lith
Mar 1, 1987·The British Journal of Ophthalmology·J F SalmonN H Welsh
Sep 1, 1985·Postgraduate Medical Journal·A M KarnikF F Fenech
Jan 1, 1985·Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde·B C PolakG H van Lith
Dec 1, 1974·American Journal of Optometry and Physiological Optics·S M Roberts
Apr 20, 1966·Annals of the New York Academy of Sciences·I G Schmidt
Apr 20, 1966·Annals of the New York Academy of Sciences·J E Leibold
May 1, 1962·Archives of Ophthalmology·R E CARR, P HENKIND
Citations
Feb 12, 2009·International Ophthalmology·Katherine Anne Talbert Estlin, Alfredo A Sadun
Dec 24, 2005·Ergonomics·Anna Luczak, Andrzej Sobolewski
Nov 5, 1997·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·R K Tsai, Y H Lee
Dec 6, 2011·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Himal KandelDev Narayan Shah
Jun 10, 2010·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·H BaatzG Scharioth
Nov 7, 2006·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Keigo ShikishimaMasaki Yoshida
Jan 13, 2017·Medicine·Wei Song, Shancheng Si
May 15, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·E K ManesisS Hadziyannis
Nov 9, 2018·PloS One·Brunella Maria Pavan TaffnerFábio Petersen Saraiva
Jun 17, 2005·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·S HadjikoutisP E M Smith
Apr 18, 2019·PloS One·Ki Won JinDong Gyu Choi
May 18, 2013·Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society·Michelle Y Wang, Alfredo A Sadun
Aug 2, 2017·Current Opinion in Ophthalmology·Paul D ChamberlainAndrew G Lee
May 21, 2011·Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society·Richard C KhoAnthony C Arnold
Sep 11, 2018·Current Eye Research·Sangah KimChan Yun Kim
Nov 8, 2013·Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society·Bridget A ScovilleBruce A Mueller
Jul 28, 2020·The British Journal of Ophthalmology·Sohini MandalRandeep Guleria
Dec 12, 2020·Scientific Reports·Yung-Ju YooHee Kyung Yang
Jun 21, 2015·Disease Models & Mechanisms·Shun-Ping HuangRong-Kung Tsai